RA Capital Management’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39M | Hold |
31,419,267
| – | – | 0.66% | 30 |
|
|
2025
Q1 | $38.3M | Hold |
31,419,267
| – | – | 0.64% | 28 |
|
|
2024
Q4 | $56.6M | Hold |
31,419,267
| – | – | 0.75% | 28 |
|
|
2024
Q3 | $160M | Hold |
31,419,267
| – | – | 1.84% | 14 |
|
|
2024
Q2 | $223M | Buy |
31,419,267
+18,268,418
| +139% | +$130M | 2.95% | 7 |
|
|
2024
Q1 | $36M | Hold |
13,150,849
| – | – | 0.46% | 48 |
|
|
2023
Q4 | $35.5M | Hold |
13,150,849
| – | – | 0.55% | 37 |
|
|
2023
Q3 | $34.6M | Hold |
13,150,849
| – | – | 0.68% | 40 |
|
|
2023
Q2 | $36.8M | Hold |
13,150,849
| – | – | 0.7% | 38 |
|
|
2023
Q1 | $38.1M | Hold |
13,150,849
| – | – | 0.86% | 35 |
|
|
2022
Q4 | $48.3M | Hold |
13,150,849
| – | – | 0.98% | 30 |
|
|
2022
Q3 | $42.5M | Hold |
13,150,849
| – | – | 0.91% | 37 |
|
|
2022
Q2 | $39.7M | Hold |
13,150,849
| – | – | 1.06% | 31 |
|
|
2022
Q1 | $110M | Hold |
13,150,849
| – | – | 2.41% | 9 |
|
|
2021
Q4 | $138M | Hold |
13,150,849
| – | – | 2.43% | 8 |
|
|
2021
Q3 | $236M | Buy |
+13,150,849
| New | +$236M | 3.28% | 3 |
|